Engineered To Outperform In Resistant Lesions
OVERVIEW
– Yukon SC Prime is a hydrophilic coated balloon catheter engineered to improve crossability and pushability to treat any lesion.
– Delivers exceptional performance needed to succeed in demanding cases
– Seamless tip design from balloon to tip for efficient energy transfer.
LESION ENTRY PROFILE (mm)
TECHNICAL SPECIFICATIONS
ORDERING MATRIX
Designed To Overcome The Anatomical Intricacies
OVERVIEW
– Yukon SC Prime is a hydrophilic coated balloon catheter engineered to improve crossability and pushability to treat any lesion.
– Delivers exceptional performance needed to succeed in demanding cases
– Seamless tip design from balloon to tip for efficient energy transfer.
LESION ENTRY PROFILE (mm)
TECHNICAL SPECIFICATIONS
ORDERING MATRIX
World’s Smallest Non-Compliant CTO Balloon
OVERVIEW
NIC Nano Hydro is the World’s smallest Non-compliant CTO Balloon with a diameter of 0.85 mm and an Ultra -low Crossing Profile of 0.019”. NIC Nano Hydro is a CE Marked access device engineered to successfully cross through Balloon Uncrossable lesions. The combination of an Ultra-low Profile, Excellent Trackability and Hydrophilic Coating are key to a successful treatment of tightest lesions and CTO’s.
THE ULTIMATE TOOL IN YOUR CTO ARMAMENTARIUM
INDICATIONS FOR USE
Successful treatment CTO’s (Chronical Total Occlusions).
The balloon of choice to gain access for Plaque Modification Devices in challenging lesions.
Re- crossing of stented side branches.
ORDER INFORMATION
Ultra High Pressure Plaque Modification Device
OVERVIEW
OPN NC is a unique Swiss made CE Marked Plaque Modification Device designed to perform in all complex lesions at Ultra-High Pressures. OPN NC utilizes Ultra-High Pressures to cause Calcium fracture or oppose Calcium to arterial wall.OPN NC is designed with a dual layer technology to withstand Ultra-High Pressures which leads to uniform expansion even at pressures as high as 45 Bars.
DESIGNED TO PERFORM IN ALL COMPLEX LESION SUBSETS
LINEAR COMPLIANCE AND UNIFORM EXPANSION
OPN NC grows less than 10 % until the Rated Burst Pressure of 35 Bars
OPN NC has a Uniform Expansion at pressure of 45 Bars as well, with no Dog Boning seen
OPN NC causes minimal perforations and no edge dissections
INDICATIONS FOR USE
For Plaque Modification in moderate to severely calcified lesions
In combination with Rotablation for large vessel diameters
Successful treatment of ISRs
DES Under Expansion due to severe calcification
Neo atherosclerosis with Calcification
Two layers of DES in combination with DEb
ISR CTo
1.5 mm smallest non compliant balloon for severely calcified coronary arteries
TIPS AND TRICKS: REMEMBER WHILE USING OPN NC
Avoid Polymer Sleeve wires and Use Extra Support Guidewires for accessing the lesions
For Pre Dilatation /treatment of DES ISR use 0.5 mm lesser diameter balloon than the Reference Vessel Diameter
For Post Dilatation 1:1 Balloon to Vessel ratio is recommended
Slow increment of pressures ( above 20 atm, increase progressively , approx. 5 atm/ 10-20 sec) for adequate luminal gain
Allow Balloon “to work/ deploy”(slight decrease in pressure due to expansion of the balloon) before increasing the pressure
Remember to De-air the Balloon and choose the correct size for optimal results at Ultra High Pressures.
OPN ID (Ultra High Pressure Inflation Device)
Sirolimus Eluting Coronary Stent System
Thin Structural Design Concomitating with Greater Deliverability
Ideal Strut Thickness
Racer CC is designed with thinner struts to provide the healing advantage associated with minimal vessel injury and better endothelialisation.
Greater Deliverability
Racer CC with its ideal strut thickness offers optimal strength, flexibility and pushability thus ensuring precise deployment
Enhanced Biocompatibility
The trusted stent platform of Racer CC has been steadily optimized with thinner struts and cell design offering better long-term outcomes
In this unique long term analysis at 10 years, Yukon has shown the lowest rate of Definite/ Probable Stent Thrombosis with a significant risk reduction than Cypher (50%) and numerically lower TLR rates as compared to Xience (29%) while maintaining the similar efficacy.
Comparison of clinical outcomes at 10 years in patients treated with new-generationBP-SES versus new-generation PP-EES versus early generation SES.
Technical Data
PRODUCT MATRIX / ORDERING INFORMATION*
COMPLIANCE CHART
Sirolimus Eluting Coronary Stent System
Thin Structural Design Concomitating with Greater Deliverability
Ideal Strut Thickness
Racer CC is designed with thinner struts to provide the healing advantage associated with minimal vessel injury and better endothelialisation.
Greater Deliverability
Racer CC with its ideal strut thickness offers optimal strength, flexibility and pushability thus ensuring precise deployment
Enhanced Biocompatibility
The trusted stent platform of Racer CC has been steadily optimized with thinner struts and cell design offering better long-term outcomes
In this unique long term analysis at 10 years, Yukon has shown the lowest rate of Definite/ Probable Stent Thrombosis with a significant risk reduction than Cypher (50%) and numerically lower TLR rates as compared to Xience (29%) while maintaining the similar efficacy.
Comparison of clinical outcomes at 10 years in patients treated with new-generationBP-SES versus new-generation PP-EES versus early generation SES.
Technical Data
PRODUCT MATRIX / ORDERING INFORMATION*
COMPLIANCE CHART
Sirolimus Eluting Coronary Stent System
Thin Structural Design Concomitating with Greater Deliverability
Ideal Strut Thickness
Racer CC is designed with thinner struts to provide the healing advantage associated with minimal vessel injury and better endothelialisation.
Greater Deliverability
Racer CC with its ideal strut thickness offers optimal strength, flexibility and pushability thus ensuring precise deployment
Enhanced Biocompatibility
The trusted stent platform of Racer CC has been steadily optimized with thinner struts and cell design offering better long-term outcomes
In this unique long term analysis at 10 years, Yukon has shown the lowest rate of Definite/ Probable Stent Thrombosis with a significant risk reduction than Cypher (50%) and numerically lower TLR rates as compared to Xience (29%) while maintaining the similar efficacy.
Comparison of clinical outcomes at 10 years in patients treated with new-generationBP-SES versus new-generation PP-EES versus early generation SES.
Technical Data
PRODUCT MATRIX / ORDERING INFORMATION*
COMPLIANCE CHART
Sirolinus Eluting Coronary Stent System
Ultimate Trackability for Treating Complexityy
Ideal Flexible Approach
Ultima PC offers new generation delivery system with ‘Flexi’ platform providing unmatched delivery in most tortuous vessels.
Enhanced Delivery System
The customized 2-Connector stent design of Ultima PC with thinner structural elements confirms for optimal deliverability.
Proprietary Hypotube
The new shaft design offers optimal force transfer with excellent push-ability and kink resistance allowing high manoeuvrability, justifying its use for the most tortuous vessels.
In this unique long term analysis at 10 years, Ultima PC has shown the lowest rate of Definite/ Probable Stent Thrombosis with a significant risk reduction than Cypher (50%) and numerically lower TLR rates as compared to Xience (29%) while maintaining the similar efficacy.
Comparison of clinical outcomes at 10 years in patients treated with new-generationBP-SES versus new-generation PP-EES versus early generation SES.
Technical Data
PRODUCT MATRIX / ORDERING INFORMATION*
COMPLIANCE CHART
Sirolinus Eluting Coronary Stent System
Ultimate Trackability for Treating Complexityy
Ideal Flexible Approach
Ultima PC offers new generation delivery system with ‘Flexi’ platform providing unmatched delivery in most tortuous vessels.
Enhanced Delivery System
The customized 2-Connector stent design of Ultima PC with thinner structural elements confirms for optimal deliverability.
Proprietary Hypotube
The new shaft design offers optimal force transfer with excellent push-ability and kink resistance allowing high manoeuvrability, justifying its use for the most tortuous vessels.
In this unique long term analysis at 10 years, Ultima PC has shown the lowest rate of Definite/ Probable Stent Thrombosis with a significant risk reduction than Cypher (50%) and numerically lower TLR rates as compared to Xience (29%) while maintaining the similar efficacy.
Comparison of clinical outcomes at 10 years in patients treated with new-generationBP-SES versus new-generation PP-EES versus early generation SES.
Technical Data
PRODUCT MATRIX / ORDERING INFORMATION*
COMPLIANCE CHART
Sirolinus Eluting Coronary Stent System
Advanced platform for redefining flexibility in tortuous anatomy
Ideal Flexible Approach
Yukon Choice Flex offers new generation delivery system with ‘Flexi’platform providing unmatched delivery in most tortuous vessels.
Enhanced Delivery System
The customized 2-Connector stent design of Yukon Choice Flex with thinner structural elements confirms for optimal deliverability.
Proprietary Hypotube
The new shaft design offers optimal force transfer with excellent push-ability and kink resistance allowing high manoeuvrability, justifying its use for the most tortuous vessels.
Unmatched Safety- In Complex Patients Subset
Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes: a pooled analysis of individual patient data from 3 randomised trials.
Long-term outcomes of biodegradable versus durable polymer drug-eluting stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of individual patient data from three randomised trials
Technical Data
PRODUCT MATRIX / ORDERING INFORMATION
COMPLIANCE CHART
